These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2573213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of carvedilol in exercise-induced myocardial ischemia.
    Kaski JC, Rodriguez-Plaza L, Brown J, Maseri A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vasodilating beta-blockers in heart failure.
    Raftery EB.
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [Abstract] [Full Text] [Related]

  • 6. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM, Freedman SB, Thomson A, Carter G, Harris PJ, Kelly DT.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The preventative effects of vasodilating beta-blockers in cardiovascular disease.
    Raftery EB.
    Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multiple action compounds in angina pectoris.
    Kelly DT, Freedman SB.
    Z Kardiol; 1989 Mar 15; 78 Suppl 3():16-20. PubMed ID: 2573212
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U, Blasini R.
    Herz; 1986 Feb 15; 11(1):55-61. PubMed ID: 2870014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC, Kang WC, Moon J, Park YM, Kim S, Kim MG, Lee K, Ahn T, Shin EK.
    Am J Cardiovasc Drugs; 2016 Jun 15; 16(3):221-8. PubMed ID: 27021556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.